Cogstate Limited
Cogstate Limited
- P/E ratio
- 35.15
Your view on CGS.AX
Overview
What the company does, where it operates, and who runs it.
About Cogstate Limited
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Bradley John O'Connor
- Headquarters
- 161 Collins Street, Melbourne, VIC, AU
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Bradley John O'Connor
- Headquarters
- 161 Collins Street, Melbourne, VIC, AU
Melbourne, Australia-based Cogstate Limited, established in 1999, is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations.
Its comprehensive suite of cognitive services includes project and data management, scientific consulting, statistical analysis, procurement of assessment scales, rater training, and monitoring solutions. The company operates through two distinct divisions.
The Clinical Trials segment delivers technology and support services designed to measure the impact of diseases, pharmaceuticals, medical devices, or other interventions on human participants in clinical studies, primarily serving pharmaceutical and biotechnology clients.
Concurrently, its Healthcare segment offers Cognigram, a system facilitating regular and standardized testing to assist primary care physicians and hospitals in the early identification of cognitive decline. By June 30, 2022, Cogstate had participated in an estimated 1,800 academic research initiatives.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Cogstate Limited from FRC's valuation model, read against the market price. CGS.AX last traded at AUD 2.59, 35.1× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cogstate Limited. Starting points for Cogstate Limited: P/E 35.1, EPS AUD 0.07, beta 0.20 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cogstate Limited. Cogstate Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cogstate Limited. Trailing twelve-month EPS for Cogstate Limited stands at AUD 0.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | $0.05 | $0.07 | $0.13 | $0.17 |
| Lowest estimate | $0.05 | $0.07 | $0.13 | $0.15 |
| Highest estimate | $0.05 | $0.07 | $0.14 | $0.20 |
| Number of analysts | 1 | 1 | 3 | 3 |
| A year ago | $0.04 | $0.06 | $0.07 | — |
| Growth vs a year ago | +43.8% | +32.1% | +92.0% | — |
Revenue estimates
| Total | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | $50.93M | $61.88M | $113.41M | $130.42M |
| Lowest estimate | $50.93M | $61.88M | $111.17M | $125.85M |
| Highest estimate | $50.93M | $61.88M | $116.81M | $134.59M |
| Number of analysts | 1 | 1 | 4 | 4 |
| A year ago | $23.94M | $30.01M | $59.87M | — |
| Growth vs a year ago | +112.7% | +106.2% | +89.4% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cogstate Limited. Cogstate Limited has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| HIQ.AXHITIQ Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| PCK.AXPainChek Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| PKY.AXPathkey.AI Ltd | Healthcare | Medical - Healthcare Information Services | — | ||
| TD1.AXTALi Digital Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| TRI.AXTrivarX Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| TEMTempus AI, Inc. | Healthcare | NASDAQ | $11.3B | ||
| TSTTFTripSitter Clinic Ltd. | Healthcare | OTC | $145,814 | ||
| TXG10x Genomics, Inc. | Healthcare | NASDAQ | $6.9B | ||
| UDOC.CNUnidoc Health Corp. | Healthcare | CNQ | $12.5M | ||
| UDOCFUnidoc Health Corp. | Healthcare | OTC | $7.6M | ||
| UMCNUMC, Inc. | Healthcare | OTC | $13.2M | ||
| UPHLUpHealth, Inc. | Healthcare | OTC | $5,679 | ||
| USPSUltimate Sports, Inc. | Healthcare | OTC | $679,298 | ||
| VASOVaso Corporation | Healthcare | OTC | $31.7M | ||
| VFX.AXVisionflex Fpo [vfx] | Healthcare | ASX | — | ||
| VHI.TOVitalhub Corp. | Healthcare | TSX | $421.8M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| AVDSAvantis International Small Cap Equity ETF | $379M in assets | 0.01% | |
| DFSIDimensional - International Sustainability Core 1 ETF | $1.2B in assets | 0.00% | |
Largest holders first, then the funds most concentrated in CGS.AX.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cogstate Limited.